{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:11:43Z","timestamp":1790079103389,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.revmed.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T19:53:24Z","timestamp":1526673204000},"page":"551-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bon usage des fluoroquinolones chez le sujet \u00e2g\u00e9 hospitalis\u00e9\u00a0: r\u00e9alisation d\u2019un audit clinique dans les h\u00f4pitaux g\u00e9riatriques des hospices civils de Lyon"],"prefix":"10.1016","volume":"39","author":[{"given":"C.","family":"Papailhau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gaujard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0226-0346","authenticated-orcid":false,"given":"L.","family":"Bourguignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mouchoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2018.03.002_bib0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.patbio.2005.07.008","article-title":"Impact de l\u2019utilisation des fluoroquinolones sur l\u2019\u00e9mergence des bact\u00e9ries multir\u00e9sistantes","volume":"53","author":"Nseir","year":"2005","journal-title":"Pathol Biol"},{"key":"10.1016\/j.revmed.2018.03.002_bib0010","series-title":"Liste des antibiotiques critiques \u2013\u00a0actualisation","author":"Rapport de l\u2019Agence nationale de la s\u00e9curit\u00e9 du m\u00e9dicament (ANSM)","year":"2015"},{"key":"10.1016\/j.revmed.2018.03.002_bib0015","unstructured":"European Centre for Disease Prevention and Control. http:\/\/ecdc.europa.eu\/en\/Pages\/home.aspx; [Acc\u00e8s au site le 16\/08\/2016]."},{"key":"10.1016\/j.revmed.2018.03.002_bib0020","author":"Chidiac","year":"2015"},{"key":"10.1016\/j.revmed.2018.03.002_bib0025","series-title":"Conduites \u00e0 tenir dans les infections du sujet \u00e2g\u00e9","author":"Veyssier","year":"2004"},{"key":"10.1016\/j.revmed.2018.03.002_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.medmal.2011.02.002","article-title":"Antibioth\u00e9rapie chez le sujet \u00e2g\u00e9\u00a0: impact d\u2019une d\u00e9marche d\u2019\u00e9valuation des pratiques professionnelles","volume":"41","author":"Raymond","year":"2011","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.revmed.2018.03.002_bib0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/11531490-000000000-00000","article-title":"Safety considerations of fluoroquinolones in the elderly: an update","volume":"27","author":"Stahlmann","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.revmed.2018.03.002_bib0040","series-title":"Fiche intervention pharmaceutique v1","author":"Soci\u00e9t\u00e9 fran\u00e7aise de pharmacie clinique (SFPC)","year":"2004"},{"key":"10.1016\/j.revmed.2018.03.002_bib0045","series-title":"Surveillance des bact\u00e9ries multir\u00e9sistantes dans les \u00e9tablissements de sant\u00e9 en France R\u00e9seau BMR-Raisin \u2013\u00a0r\u00e9sultats","author":"Institut de veille sanitaire (InVS)","year":"2013"},{"key":"10.1016\/j.revmed.2018.03.002_bib0050","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.medmal.2010.06.002","article-title":"\u00c9valuation de l\u2019antibioth\u00e9rapie des bact\u00e9ri\u00e9mies et place d\u2019une \u00e9quipe mobile pour l\u2019am\u00e9lioration de la prescription antibiotique","volume":"40","author":"Diamantis","year":"2010","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.revmed.2018.03.002_bib0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.encep.2014.10.001","article-title":"Interventions pharmaceutiques \u00e9mises par les pharmaciens sur les m\u00e9dicaments psychotropes","volume":"41","author":"Parent","year":"2015","journal-title":"Encephale"},{"key":"10.1016\/j.revmed.2018.03.002_bib0060","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1345\/aph.1L045","article-title":"Assessment of clinical pharmacists\u2019 interventions in French hospitals: results of a multicenter study","volume":"42","author":"Bedouch","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.revmed.2018.03.002_bib0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/jcpt.12214","article-title":"Trends in pharmacists\u2019 medication order review in French hospitals from 2006\u00a0to 2009: analysis of pharmacists\u2019 interventions from the Act-IP\u00a9 website observatory","volume":"40","author":"Bedouch","year":"2015","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.revmed.2018.03.002_bib0070","first-page":"2","article-title":"Les interventions pharmaceutiques dans un centre hospitalier universitaire\u00a0: influence du mode de transmission sur leur acceptation par le prescripteur","volume":"51","author":"Renaudin","year":"2016","journal-title":"Pharm Hosp Clin"},{"key":"10.1016\/j.revmed.2018.03.002_bib0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1294-5501(04)94257-4","article-title":"Antibioth\u00e9rapie et personnes \u00e2g\u00e9es","volume":"6","author":"Trivalle","year":"2004","journal-title":"Antibiotiques"},{"key":"10.1016\/j.revmed.2018.03.002_bib0080","first-page":"167","article-title":"Sp\u00e9cificit\u00e9s de la personne \u00e2g\u00e9e et leurs cons\u00e9quences sur la prise en charge m\u00e9dicamenteuse","volume":"30","author":"Mangerel","year":"2011","journal-title":"J Pharm Clin"},{"key":"10.1016\/j.revmed.2018.03.002_bib0085","first-page":"15","article-title":"Les infections urinaires chez les personnes \u00e2g\u00e9es","volume":"4","author":"Pinganaud","year":"2004","journal-title":"NPG"},{"key":"10.1016\/j.revmed.2018.03.002_bib0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.medmal.2009.08.022","article-title":"Revue de pertinence des fluoroquinolones en Lorraine\u00a0: r\u00e9sultats de la premi\u00e8re \u00e9valuation","volume":"40","author":"Doco-Lecompte","year":"2010","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.revmed.2018.03.002_bib0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.patbio.2010.03.004","article-title":"Revue de pertinence de la prescription des fluoroquinolones au CHU de Nancy\u00a0: r\u00e9sultats du premier tour","volume":"59","author":"Desmots","year":"2011","journal-title":"Pathol Biol"},{"key":"10.1016\/j.revmed.2018.03.002_bib0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10096-004-1246-x","article-title":"Optimizing fluoroquinolone utilization in a publichospital: a prospective study of educational intervention","volume":"24","author":"Lacombe","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.revmed.2018.03.002_bib0105","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1086\/500319","article-title":"Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study","volume":"42","author":"Charbonneau","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2018.03.002_bib0110","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.lpm.2007.01.038","article-title":"Bon usage des antibiotiques\u00a0: optimisation du relais per os des fluoroquinolones","volume":"36","author":"Rigaud","year":"2007","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2018.03.002_bib0115","first-page":"239","article-title":"Analyse m\u00e9dico-\u00e9conomique des pratiques de prescription des fluoroquinolones injectables","volume":"22","author":"Bedouch","year":"2004","journal-title":"J Econ Med"},{"key":"10.1016\/j.revmed.2018.03.002_bib0120","first-page":"33","article-title":"Rationalisation des voies d\u2019administration du parac\u00e9tamol\u00a0: quelles actions\u00a0? Quel impact \u00e0 l\u2019h\u00f4pital\u00a0?","volume":"52","author":"Baudon-Lecame","year":"2017","journal-title":"Pharm Hosp Clin"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318300845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318300845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:39:03Z","timestamp":1759336743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866318300845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0248866318300845"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2018.03.002","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bon usage des fluoroquinolones chez le sujet \u00e2g\u00e9 hospitalis\u00e9\u00a0: r\u00e9alisation d\u2019un audit clinique dans les h\u00f4pitaux g\u00e9riatriques des hospices civils de Lyon","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}